Ben Tre Pharmaceutical JSC

Ben Tre Pharmaceutical JSC EBITDA

The EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Ben Tre Pharmaceutical JSC (DBT.VN) as of Oct 31, 2026 is 61.45 B VND. In the previous year, EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) was 73.75 B VND — a change of -16.67% (lower).

EBITDA

61.45 BVND

YoY

-16.67%

Last updated:

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Ben Tre Pharmaceutical JSC is 2024 61.45 B VND. EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Ben Tre Pharmaceutical JSC was 2023 73.75 B VND. It decreases by -16.67% lower compared to the previous year.

The Ben Tre Pharmaceutical JSC EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA
Date
EBITDA
Jan 1, 2014
14.21 B VND
Jan 1, 2015
6.34 B VND
Jan 1, 2020
34.05 B VND
Jan 1, 2021
14.90 B VND
Jan 1, 2022
38.99 B VND
Jan 1, 2023
73.75 B VND
Jan 1, 2024
61.45 B VND
The Ben Tre Pharmaceutical JSC EBITDA history
YEAREBITDAYoY
61.45 BVND-16.67%
73.75 BVND+89.12%
38.99 BVND+161.69%
14.90 BVND-56.23%
34.05 BVND+437.36%
6.34 BVND-55.42%
14.21 BVND—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Ben Tre Pharmaceutical JSC Stock analysis

What does Ben Tre Pharmaceutical JSC do? Ben Tre Pharmaceutical JSC manufactures and distributes pharmaceutical products, including medicinal products through its subsidiaries. The company wholesales, imports, and exports pharmaceuticals, materials, chemicals, packagings, and biological products. It also retails drugs and trades supplements, medical equipment, supplies, and machinery. The firm rents commercial space for additional revenue. Its primary customers are healthcare providers, pharmacies, and medical institutions requiring pharmaceuticals and medical supplies. The company's revenue streams include pharmaceutical manufacturing, wholesale distribution, import/export services, retail drug sales, and commercial space rentals. Key segments are pharmaceuticals, medical equipment, and biological products. The firm serves healthcare sectors through its subsidiaries and direct retail channels. Revenue is generated from both domestic and international trade activities. Ben Tre Pharmaceutical JSC's products include pharmaceuticals, medicinal products, medical equipment, and supplements. The company's brands are not specified in the business description. It targets healthcare providers, pharmacies, and medical institutions as its main buyers. The firm's operations span manufacturing, distribution, retail, and commercial leasing within the pharmaceutical and medical sectors. Ben Tre Pharmaceutical JSC is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Ben Tre Pharmaceutical JSC stock

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Ben Tre Pharmaceutical JSC is 61.45 B VND in 2024.

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Ben Tre Pharmaceutical JSC changed from 73.75 B VND to 61.45 B VND, representing a -16.67% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) Ben Tre Pharmaceutical JSC since 2006 – with annual values, charts, and detailed analysis.

EBITDA measures operating performance before the impact of financial structure, tax environment, and non-cash depreciation charges.

EBITDA = EBIT + Depreciation & Amortization

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s VND is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s Ben Tre Pharmaceutical JSC historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — Ben Tre Pharmaceutical JSC

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Ben Tre Pharmaceutical JSC